Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Knee Braces Can Help Treat ACL Injuries

Have you ever watched an athletic event on TV and seen an athlete fall to the ground clutching his or her knee in agony? If so, there is a decent chance you witnessed an ACL tear. ACL injuries tend to be extremely painful, and it is important to seek and secure swift and proper treatment….

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Have you ever watched an athletic event on TV and seen an athlete fall to the ground clutching his or her knee in agony? If so, there is a decent chance you witnessed an ACL tear. ACL injuries tend to be extremely painful, and it is important to seek and secure swift and proper treatment. Handling these injuries appropriately will ensure that patients regain maximum strength and movement in the joint and increase the efficiency of the rehabilitation process. The level of injury and the required degree of recovery will determine the best treatment options. These can include rest, physiotherapy, wearing an ACL brace and/or undergoing reconstructive surgery, or possibly a combination of all of these.

Causes and Symptoms

ACL injuries denote a tear or sprain in the anterior cruciate ligament (ACL)––a major knee ligament. Ligaments are strong bands of tissue that connect bones. The ACL crosses the knee and connects your thighbone (femur) to your shinbone (tibia). Sports that involve sudden stops, changes in direction, or jumping and landing are common culprits of this injury.1 Activities in which direct blows occur can also increase the likelihood of an ACL tear or ACL sprain. In addition to engagement in the aforementioned activities, other risk factors include being female and wearing ill-fitting footwear during high activity. When this injury happens, many people hear or feel a “pop” in the knee and may experience swelling, pain, and instability. The severity of the injury will affect the symptoms and determine the best treatment approach.

ACL Treatment Plans

The treatment program for an ACL tear or ACL sprain will depend on several factors and range from first aid to surgery. Ice, elevation, and rest for the knee are the first line of defense. Doctors can also prescribe anti-inflammatory medications or offer steroid injections if warranted. A proper knee brace can also offer support while healing. In addition, physical therapy to strengthen the muscles around the knee can help patients regain a full range of motion. And if the ACL is badly torn, surgery might be unavoidable. During this procedure, the surgeon removes the damaged ACL and replaces it with tissue that stimulates new ligament growth.2 The best treatment approach will restore stability while helping prevent future damage. It’s critical that patients follow their doctor’s advice during recovery and use a proper knee brace, or they may face a lifetime of unnecessary residual difficulties following an ACL injury.

Knee Brace Options

Below are some of our best selling knee braces from mild to moderate support and postoperative management.

FREEDOM® Breathable Hinged Knee Brace: is a soft hinged knee brace for mild/moderate ACL instabilities.

FREEDOM® Hinged Extended-Length Knee Orthosis: recommended for ACL instabilities and post-op management.

Ossur® Rebound® DUAL: a functional ligament knee brace that is suitable for low to high impact activities.

For our full line of knee braces and knee supports,click here.

References

  1. https://www.mayoclinic.org/diseases-conditions/acl-injury/symptoms-causes/syc-20350738
  2. https://www.webmd.com/pain-management/knee-pain/acl-injury-what-to-know#2

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512